S041 Hair Loss from Trichoscopy to Therapy
DESCRIPTION
Trichoscopy has become an important adjunctive method in the differential diagnosis of hair loss and may influence therapeutic decisions. This session will provide an update on trichoscopic clues for the diagnosis of hair loss and the management of patients with selected hair disorders (e.g., androgenetic alopecia, alopecia areata, lichen planopilaris, fibrosing alopecia in a pattern distribution, pseudopelade, dissecting cellulitis, folliculitis decalvans, dissecting cellulitis, GLP-1 inhibitor-related alopecia). Specific features of cicatricial alopecia in skin of color will also be discussed. UV-enhanced trichoscopy will be presented. New treatments and updated treatment algorithms for hair loss will be reviewed.
LEARNING OBJECTIVES
Diagnose hair loss more effectively
Identify trichoscopy clues for the diagnosis of common hair diseases
Treat hair loss more effectively
SCHEDULE
1:00 PM
Can We Prevent Hair Loss Associated with GLP-1 Inhibitors?
Antonella Tosti, MD
1:12 PM
Lichen Planopilaris and Its Subtypes: What’s New?
Lidia Rudnicka, MD, PhD, IFAAD
1:24 PM
How to Select and Switch Between JAK Inhibitors in Alopecia Areata
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
1:36 PM
Cicatricial Alopecias in Skin of Color
Amy J. McMichael, MD, FAAD
1:48 PM
Q&A - Cicatricial Alopecia
Lidia Rudnicka, MD, PhD, IFAAD, Amy J. McMichael, MD, FAAD, Daniel Melo, MD, MS, PhD, IFAAD
2:00 PM
How to Avoid Misdiagnosing Alopecia Areata?
Mariya Miteva, MD
2:12 PM
Treatment Algorithms for Alopecia Areata
Rodney Daniel Sinclair, MD, IFAAD
2:24 PM
Dissecting Cellulitis and Folliculitis Decalvans: From Trichoscopy to New Therapies
Daniel Melo, MD, MS, PhD, IFAAD
2:36 PM
Q&A - Alopecia Areata
Lidia Rudnicka, MD, PhD, IFAAD, Natasha Atanaskova Mesinkovska, PhD, MD, FAAD, Mariya Miteva, MD
2:46 PM
How to Avoid Misdiagnosing Androgenetic Alopecia in Women and Men
Rodrigo Pirmez, MD
2:58 PM
Systemic Treatment of Androgenetic Alopecia: What’s New?
Jerry Shapiro, MD, FAAD
3:10 PM
Topical and Injectable Treatments for Androgenetic Alopecia
Isabella Doche, MD, PhD, IFAAD
3:22 PM
Q&A - Androgenetic Alopecia
Lidia Rudnicka, MD, PhD, IFAAD, Isabella Doche, MD, PhD, IFAAD, Rodrigo Pirmez, MD, Jerry Shapiro, MD, FAAD
3:35 PM
Filler-Induced Alopecia: Clinical Presentation and Trichoscopy
Daniel Asz-Sigall, MD, IFAAD
3:45 PM
UV-Enhanced Trichoscopy
Luis Enrique Sanchez Duenas, MD
3:55 PM
Q&A
Lidia Rudnicka, MD, PhD, IFAAD, Daniel Asz-Sigall, MD, IFAAD, Luis Enrique Sanchez Duenas, MD
DIRECTOR
Lidia Rudnicka, MD, PhD, IFAAD
Medical University of Warszaw
SPEAKERS
Daniel Asz-Sigall, MD, IFAAD
Trichology Clinic, Dr Manuel Gea Gonzalez General Hospital, Mexico City. Mexico
Isabella Doche, MD, PhD, IFAAD
Amy J. McMichael, MD, FAAD
Professor, Department of Dermatology, Wake Forest University School of Medicine
Daniel Melo, MD, MS, PhD, IFAAD
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
Mariya Miteva, MD
Rodrigo Pirmez, MD
Santa Casa da Misericórdia do Rio de Janeiro, Brazil
Luis Enrique Sanchez Duenas, MD
Jerry Shapiro, MD, FAAD
Rodney Daniel Sinclair, MD, IFAAD
Antonella Tosti, MD
DISCLOSURES
Daniel Asz-Sigall, MD, IFAAD
No financial relationships exist with ineligible companies.
Isabella Doche, MD, PhD, IFAAD
Ache Laboratório Farmaceuticso S.A. – Speaker/Faculty Education(Fees); Cantabria Labs – Speaker/Faculty Education(Fees); Fotofinder – Other(Equipment); GlaxoSmithKline Immunology – Speaker/Faculty Education(Fees); L'Oreal – Speaker/Faculty Education(Fees); Mantecorp – Consultant (1099 relationship)(Fees); Panalab – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker/Faculty Education(Fees); Pierre Fabre – Speaker/Faculty Education(Fees); TheraSkin Farmacêutica – Consultant (1099 relationship)(Fees);
Amy J. McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Daniel Melo, MD, MS, PhD, IFAAD
No financial relationships exist with ineligible companies.
Natasha Atanaskova Mesinkovska, PhD, MD, FAAD
AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Mariya Miteva, MD
Absci – Advisory Board(Honoraria); Cassiopea, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Informa – Other(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Lidia Rudnicka, MD, PhD, IFAAD
La Roche-Posay Laboratoire Pharmaceutique – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees);
Luis Enrique Sanchez Duenas, MD
No financial relationships exist with ineligible companies.
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);
Rodney Daniel Sinclair, MD, IFAAD
AbbVie – Advisory Board(Fees); Aclaris Therapeutics Inc. – Investigator(Fees); Amgen – Investigator(Fees); Ascend Pharmaceuticals, Inc. – Board of Directors(Fees); Bayer – Speaker/Faculty Education(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botaneco – Investigator(Fees); Celgene Corporation – Investigator(Fees); Coherus Biosciences – Investigator(Fees); CSL – Consultant(Fees); Cutanea Life Sciences – Investigator(Fees); Eli Lilly and Company – Advisory Board(Fees); GlaxoSmithKline – Investigator(Fees); inVentiv Health – Investigator(Fees); Janssen Pharmaceuticals, Inc – Other(Fees); Johnson & Johnson Pharmaceutical Research & Development – Investigator(Fees); Leo Pharma Inc – Advisory Board(Fees); Medimmune – Investigator(Fees); Medpace – Investigator(Fees); Merck & Co., Inc – Investigator(Fees); Merck Serono – Investigator(Fees); Novartis – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Fees); PhotonMD, Inc. – Investigator(Fees); PPD Inc. – Investigator(Fees); Principia Biopharma Inc – Investigator(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Fees); Reistone Biopharma – Investigator(Fees); Revian LTD. – Investigator(Fees); Samson Clinical – Founder(Patent royalties or other compensation for Intellectual Property Rights); UCB – Investigator(Fees);
Antonella Tosti, MD
Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);